Pending — not yet graded
“Upgraded Dr. Agarwal's Health Care to 'buy' from 'hold' on August 5, with a target of ₹600 per share, indicating a 19.6% upside from its previous close. This suggests a strong conviction in the stock's future performance.”
Jefferies Analysis’s track record: 3 graded calls · 95% CI 44–100%
Dr. Agarwal's Health CareBullishCalled 20 Aug 2026
This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.